Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
5(28%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
44%
Ph phase_2
6
33%
Ph phase_1
1
6%
Ph phase_3
3
17%

Phase Distribution

1

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
1(5.6%)
Phase 2Efficacy & side effects
6(33.3%)
Phase 3Large-scale testing
3(16.7%)
N/ANon-phased studies
8(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

18

all time

Status Distribution
Active(7)
Completed(8)
Other(3)

Detailed Status

Completed8
Recruiting4
unknown3
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (5.6%)
Phase 26 (33.3%)
Phase 33 (16.7%)
N/A8 (44.4%)

Trials by Status

not_yet_recruiting211%
active_not_recruiting16%
recruiting422%
completed844%
unknown317%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07147179Not Applicable

Short Course Radiotherapy

Recruiting
NCT06787183Phase 2

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Recruiting
NCT06052332Not Applicable

Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer

Recruiting
NCT07118800Phase 3

Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

Not Yet Recruiting
NCT06848465Phase 1

LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis

Recruiting
NCT02945566Phase 2

Can We Save the Rectum by Watchful Waiting or TransAnal Surgery Following (chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?

Active Not Recruiting
NCT06521827Not Applicable

The Role of Short Course of Palliative Radiation in Metastatic Cancer Rectum

Not Yet Recruiting
NCT05527821Phase 2

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Unknown
NCT01923987Phase 2

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

Unknown
NCT03922152Not Applicable

2D-radiotherapy in Palliation of Advanced Esophageal Cancer

Completed
NCT03947268Not Applicable

Radiotherapy in Palliation of Advanced Pelvic Cancer

Completed
NCT03465553Not Applicable

Palliative Short Course Radiotherapy for Advanced Thoracic Cancer

Completed
NCT03455231Not Applicable

Short Course Radiotherapy in Complicated Bone Metastases Palliation

Completed
NCT03196700Not Applicable

Short Course Radiation Therapy in Palliative Treatment

Completed
NCT01269229Phase 2

A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis

Completed
NCT02510378Phase 2

Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases

Unknown
NCT00145769Phase 3

A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum

Completed
NCT00665197Phase 3

Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia

Completed

All 18 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
18